Conceptus Reports Third Quarter Financial Results; Announces Accelerating Pivotal Trial Enrollment and Marketing Activities.

Extract


Conceptus Reports Third Quarter Financial Results; Announces Accelerating Pivotal Trial Enrollment and Marketing Activities.

Business Editors

SAN CARLOS, Calif.--(BUSINESS WIRE)--Oct. 19, 2000

Conceptus, Inc. (NASDAQ NM: CPTS), developer of the STOP(TM) (Selective Tubal Occlusion Procedure) non-surgical permanent contraception device for women, today announced financial results for the three and nine months ended September 30, 2000.

For the third quarter of 2000, the Compan...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company